DLRHX Performance — Nomura Healthcare Fund, Class R
Data updated: 2026-08-26
DLRHX returned +5.21% year to date and +31.32% over one year to Jun 2026. Annualised returns are +14.14% over 3 years and +7.40% over 5 years. Against its Health Care Equity category average the fund came out ahead over three years but behind over one: $100 invested three years ago grew to $149, against $138 for the category, and to $131 over one year, against $137. Volatility over the past three years was 13.60% a year. In the 12 months to Jun 2026 the fund lost a net $14.5M, and assets reached $750.22M.
DLRHX Growth of $100
What $100 invested in Nomura Healthcare Fund grew to, compounded from monthly returns reported on SEC Form N-PORT, against the Health Care Equity category average over the same months.
| Period | DLRHX | Category average |
|---|---|---|
| 1 year (Jul 2025 – Jun 2026) | $131 | $137 |
| 3 years (Jul 2023 – Jun 2026) | $149 | $138 |
| 5 years (Jul 2021 – Jun 2026) | $143 | $121 |
| Since data start (Jul 2019 – Jun 2026) | $190 | $182 |
DLRHX Trailing Returns
Total returns to Jun 2026, from SEC N-PORT.
| Period | Total return |
|---|---|
| YTD | +5.21% |
| 1 year | +31.32% |
| 3 years (annualised) | +14.14% |
| 5 years (annualised) | +7.40% |
DLRHX Annual Returns
Calendar-year total returns of Nomura Healthcare Fund, compounded from monthly SEC N-PORT returns. Partial years show the months covered.
| Year | Total return |
|---|---|
| 2026 (Jan–Jun) | +5.21% |
| 2025 | +21.78% |
| 2024 | +8.18% |
| 2023 | +3.96% |
| 2022 | −1.57% |
| 2021 | +5.06% |
| 2020 | +10.89% |
| 2019 (Jul–Dec) | +15.14% |
DLRHX Monthly Returns
Monthly total returns as reported on SEC Form N-PORT.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | +0.4% | +2.4% | −5.7% | +0.5% | +1.7% | +6.1% | — | — | — | — | — | — |
| 2025 | +4.2% | +0.8% | −3.9% | +0.1% | −5.1% | +1.8% | −0.9% | +7.4% | +4.2% | +5.1% | +8.4% | −1.2% |
| 2024 | +2.9% | +5.9% | +2.0% | −4.2% | +1.5% | +2.9% | +3.8% | +5.9% | −3.6% | −3.0% | −1.0% | −4.4% |
| 2023 | −0.9% | −4.6% | +2.0% | +2.4% | −3.0% | +1.2% | +1.4% | +0.7% | −3.1% | −4.1% | +5.2% | +7.4% |
| 2022 | −5.1% | −1.3% | +4.7% | −5.5% | +0.4% | −1.3% | +1.6% | −4.7% | −1.8% | +8.7% | +5.6% | −1.9% |
| 2021 | +1.8% | −1.4% | −1.5% | +2.2% | +0.2% | +2.9% | −2.5% | +2.8% | −4.4% | +2.6% | −5.0% | +7.9% |
| 2020 | −5.3% | −3.5% | −6.4% | +13.2% | +7.0% | +0.3% | −0.7% | +1.1% | −1.7% | −4.0% | +9.4% | +2.9% |
| 2019 | — | — | — | — | — | — | −0.7% | −2.3% | −1.6% | +6.4% | +6.3% | +6.6% |
DLRHX Risk
Risk measures from monthly returns over Jul 2023 – Jun 2026.
- 3-year volatility (annualised): 13.60%
- 3-year Sharpe ratio: 0.71 (vs 4.5% risk-free rate)
- Best month: +8.36% (Nov 2025)
- Worst month: −5.72% (Mar 2026)
DLRHX Fund Flows
Monthly money in and out of Nomura Healthcare Fund, from SEC Form N-PORT.
- 12-month net flow: −$14.5M
- 12-month gross sales (incl. reinvestments): $223.7M
- Sales ÷ redemptions: 0.94×
| Month | Sales | Redemptions | Net flow |
|---|---|---|---|
| Jun 2026 | $15.6M | $12.1M | $3.5M |
| May 2026 | $14.3M | $15.0M | −$711K |
| Apr 2026 | $43.1M | $19.6M | $23.5M |
| Mar 2026 | $14.5M | $15.3M | −$794K |
| Feb 2026 | $11.8M | $10.0M | $1.8M |
| Jan 2026 | $17.5M | $27.3M | −$9.8M |
| Dec 2025 | $73.5M | $29.8M | $43.7M |
| Nov 2025 | $6.8M | $13.0M | −$6.2M |
| Oct 2025 | $5.5M | $17.2M | −$11.7M |
| Sep 2025 | $4.4M | $26.6M | −$22.3M |
| Aug 2025 | $9.8M | $26.2M | −$16.4M |
| Jul 2025 | $6.8M | $25.9M | −$19.1M |
DLRHX Assets Under Management
Net assets of Nomura Healthcare Fund by report date, from SEC N-PORT filings.
| Report date | Net assets |
|---|---|
| 2026-06-30 | $750.22M |
| 2026-03-31 | $664.98M |
| 2025-12-31 | $693.63M |
| 2025-09-30 | $658.37M |
| 2025-06-30 | $648.02M |
| 2025-03-31 | $702.34M |
| 2024-12-31 | $701.86M |
| 2024-09-30 | $835.41M |
| 2024-06-28 | $784.16M |
| 2024-03-28 | $791.40M |
| 2023-12-29 | $725.26M |
| 2023-09-29 | $731.69M |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.